The global market for Virus-like Particle was estimated to be worth US$ 326 million in 2023 and is forecast to a readjusted size of US$ 585.5 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030

Virus-like Particle - Market

Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Virus-like Particle, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Virus-like Particle by region & country, by Type, and by Application.

The Virus-like Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virus-like Particle.

Market Segmentation

Scope of Virus-like Particle - Market Report

Report Metric	Details
Report Name	Virus-like Particle - Market
Forecasted market size in 2030	US$ 585.5 million
CAGR	8.8%
Forecasted years	2024 - 2030
Segment by Type:	E. coli Yeast Insect Cells Others
Segment by Application	Vaccine Therapeutics Bioimaging Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	The Native Antigen Company, Creative BioStructure, Creative Biolabs, Leadgene Biomedical, Abcam, ACROBiosystems, Gentarget, VectorBuilder
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Virus-like Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Virus-like Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Virus-like Particle in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Virus-like Particle - Market size in 2030?

Ans: The Virus-like Particle - Market size in 2030 will be US$ 585.5 million.

Who are the main players in the Virus-like Particle - Market report?

Ans: The main players in the Virus-like Particle - Market are The Native Antigen Company, Creative BioStructure, Creative Biolabs, Leadgene Biomedical, Abcam, ACROBiosystems, Gentarget, VectorBuilder

What are the Application segmentation covered in the Virus-like Particle - Market report?

Ans: The Applications covered in the Virus-like Particle - Market report are Vaccine, Therapeutics, Bioimaging, Others

What are the Type segmentation covered in the Virus-like Particle - Market report?

Ans: The Types covered in the Virus-like Particle - Market report are E. coli, Yeast, Insect Cells, Others

1 Market Overview

1.1 Virus-like Particle Product Introduction

1.2 Global Virus-like Particle Market Size Forecast

1.2.1 Global Virus-like Particle Sales Value (2019-2030)

1.2.2 Global Virus-like Particle Sales Volume (2019-2030)

1.2.3 Global Virus-like Particle Sales Price (2019-2030)

1.3 Virus-like Particle Market Trends & Drivers

1.3.1 Virus-like Particle Industry Trends

1.3.2 Virus-like Particle Market Drivers & Opportunity

1.3.3 Virus-like Particle Market Challenges

1.3.4 Virus-like Particle Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Virus-like Particle Players Revenue Ranking (2023)

2.2 Global Virus-like Particle Revenue by Company (2019-2024)

2.3 Global Virus-like Particle Players Sales Volume Ranking (2023)

2.4 Global Virus-like Particle Sales Volume by Company Players (2019-2024)

2.5 Global Virus-like Particle Average Price by Company (2019-2024)

2.6 Key Manufacturers Virus-like Particle Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Virus-like Particle Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Virus-like Particle

2.9 Virus-like Particle Market Competitive Analysis

2.9.1 Virus-like Particle Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Virus-like Particle Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particle as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 E. coli

3.1.2 Yeast

3.1.3 Insect Cells

3.1.4 Others

3.2 Global Virus-like Particle Sales Value by Type

3.2.1 Global Virus-like Particle Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Virus-like Particle Sales Value, by Type (2019-2030)

3.2.3 Global Virus-like Particle Sales Value, by Type (%) (2019-2030)

3.3 Global Virus-like Particle Sales Volume by Type

3.3.1 Global Virus-like Particle Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Virus-like Particle Sales Volume, by Type (2019-2030)

3.3.3 Global Virus-like Particle Sales Volume, by Type (%) (2019-2030)

3.4 Global Virus-like Particle Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Vaccine

4.1.2 Therapeutics

4.1.3 Bioimaging

4.1.4 Others

4.2 Global Virus-like Particle Sales Value by Application

4.2.1 Global Virus-like Particle Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Virus-like Particle Sales Value, by Application (2019-2030)

4.2.3 Global Virus-like Particle Sales Value, by Application (%) (2019-2030)

4.3 Global Virus-like Particle Sales Volume by Application

4.3.1 Global Virus-like Particle Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Virus-like Particle Sales Volume, by Application (2019-2030)

4.3.3 Global Virus-like Particle Sales Volume, by Application (%) (2019-2030)

4.4 Global Virus-like Particle Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Virus-like Particle Sales Value by Region

5.1.1 Global Virus-like Particle Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Virus-like Particle Sales Value by Region (2019-2024)

5.1.3 Global Virus-like Particle Sales Value by Region (2025-2030)

5.1.4 Global Virus-like Particle Sales Value by Region (%), (2019-2030)

5.2 Global Virus-like Particle Sales Volume by Region

5.2.1 Global Virus-like Particle Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Virus-like Particle Sales Volume by Region (2019-2024)

5.2.3 Global Virus-like Particle Sales Volume by Region (2025-2030)

5.2.4 Global Virus-like Particle Sales Volume by Region (%), (2019-2030)

5.3 Global Virus-like Particle Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Virus-like Particle Sales Value, 2019-2030

5.4.2 North America Virus-like Particle Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Virus-like Particle Sales Value, 2019-2030

5.5.2 Europe Virus-like Particle Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Virus-like Particle Sales Value, 2019-2030

5.6.2 Asia Pacific Virus-like Particle Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Virus-like Particle Sales Value, 2019-2030

5.7.2 South America Virus-like Particle Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Virus-like Particle Sales Value, 2019-2030

5.8.2 Middle East & Africa Virus-like Particle Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Virus-like Particle Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Virus-like Particle Sales Value

6.2.1 Key Countries/Regions Virus-like Particle Sales Value, 2019-2030

6.2.2 Key Countries/Regions Virus-like Particle Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Virus-like Particle Sales Value, 2019-2030

6.3.2 United States Virus-like Particle Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Virus-like Particle Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Virus-like Particle Sales Value, 2019-2030

6.4.2 Europe Virus-like Particle Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Virus-like Particle Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Virus-like Particle Sales Value, 2019-2030

6.5.2 China Virus-like Particle Sales Value by Type (%), 2023 VS 2030

6.5.3 China Virus-like Particle Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Virus-like Particle Sales Value, 2019-2030

6.6.2 Japan Virus-like Particle Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Virus-like Particle Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Virus-like Particle Sales Value, 2019-2030

6.7.2 South Korea Virus-like Particle Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Virus-like Particle Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Virus-like Particle Sales Value, 2019-2030

6.8.2 Southeast Asia Virus-like Particle Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Virus-like Particle Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Virus-like Particle Sales Value, 2019-2030

6.9.2 India Virus-like Particle Sales Value by Type (%), 2023 VS 2030

6.9.3 India Virus-like Particle Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 The Native Antigen Company

7.1.1 The Native Antigen Company Company Information

7.1.2 The Native Antigen Company Introduction and Business Overview

7.1.3 The Native Antigen Company Virus-like Particle Sales, Revenue and Gross Margin (2019-2024)

7.1.4 The Native Antigen Company Virus-like Particle Product Offerings

7.1.5 The Native Antigen Company Recent Development

7.2 Creative BioStructure

7.2.1 Creative BioStructure Company Information

7.2.2 Creative BioStructure Introduction and Business Overview

7.2.3 Creative BioStructure Virus-like Particle Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Creative BioStructure Virus-like Particle Product Offerings

7.2.5 Creative BioStructure Recent Development

7.3 Creative Biolabs

7.3.1 Creative Biolabs Company Information

7.3.2 Creative Biolabs Introduction and Business Overview

7.3.3 Creative Biolabs Virus-like Particle Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Creative Biolabs Virus-like Particle Product Offerings

7.3.5 Creative Biolabs Recent Development

7.4 Leadgene Biomedical

7.4.1 Leadgene Biomedical Company Information

7.4.2 Leadgene Biomedical Introduction and Business Overview

7.4.3 Leadgene Biomedical Virus-like Particle Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Leadgene Biomedical Virus-like Particle Product Offerings

7.4.5 Leadgene Biomedical Recent Development

7.5 Abcam

7.5.1 Abcam Company Information

7.5.2 Abcam Introduction and Business Overview

7.5.3 Abcam Virus-like Particle Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Abcam Virus-like Particle Product Offerings

7.5.5 Abcam Recent Development

7.6 ACROBiosystems

7.6.1 ACROBiosystems Company Information

7.6.2 ACROBiosystems Introduction and Business Overview

7.6.3 ACROBiosystems Virus-like Particle Sales, Revenue and Gross Margin (2019-2024)

7.6.4 ACROBiosystems Virus-like Particle Product Offerings

7.6.5 ACROBiosystems Recent Development

7.7 Gentarget

7.7.1 Gentarget Company Information

7.7.2 Gentarget Introduction and Business Overview

7.7.3 Gentarget Virus-like Particle Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Gentarget Virus-like Particle Product Offerings

7.7.5 Gentarget Recent Development

7.8 VectorBuilder

7.8.1 VectorBuilder Company Information

7.8.2 VectorBuilder Introduction and Business Overview

7.8.3 VectorBuilder Virus-like Particle Sales, Revenue and Gross Margin (2019-2024)

7.8.4 VectorBuilder Virus-like Particle Product Offerings

7.8.5 VectorBuilder Recent Development

8 Industry Chain Analysis

8.1 Virus-like Particle Industrial Chain

8.2 Virus-like Particle Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Virus-like Particle Sales Model

8.5.2 Sales Channel

8.5.3 Virus-like Particle Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

The Native Antigen Company

Creative Biostructure

List of Tables

Table 1. Virus-like Particle Market Trends

Table 2. Virus-like Particle Market Drivers & Opportunity

Table 3. Virus-like Particle Market Challenges

Table 4. Virus-like Particle Market Restraints

Table 5. Global Virus-like Particle Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Virus-like Particle Revenue Market Share by Company (2019-2024)

Table 7. Global Virus-like Particle Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Virus-like Particle Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Virus-like Particle Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Virus-like Particle Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Virus-like Particle Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Virus-like Particle

Table 13. Global Virus-like Particle Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particle as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Virus-like Particle Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Virus-like Particle Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Virus-like Particle Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Virus-like Particle Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Virus-like Particle Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Virus-like Particle Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Virus-like Particle Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Virus-like Particle Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Virus-like Particle Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Virus-like Particle Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Virus-like Particle Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Virus-like Particle Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Virus-like Particle Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Virus-like Particle Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Virus-like Particle Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Virus-like Particle Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Virus-like Particle Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Virus-like Particle Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Virus-like Particle Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Virus-like Particle Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Virus-like Particle Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Virus-like Particle Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Virus-like Particle Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Virus-like Particle Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Virus-like Particle Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Virus-like Particle Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Virus-like Particle Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Virus-like Particle Sales Value by Region (2019-2024) & (%)

Table 44. Global Virus-like Particle Sales Value by Region (2025-2030) & (%)

Table 45. Global Virus-like Particle Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Virus-like Particle Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Virus-like Particle Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Virus-like Particle Sales Volume by Region (2019-2024) & (%)

Table 49. Global Virus-like Particle Sales Volume by Region (2025-2030) & (%)

Table 50. Global Virus-like Particle Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Virus-like Particle Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Virus-like Particle Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Virus-like Particle Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Virus-like Particle Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Virus-like Particle Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Virus-like Particle Sales Volume, (2025-2030) & (K Units)

Table 57. The Native Antigen Company Company Information

Table 58. The Native Antigen Company Introduction and Business Overview

Table 59. The Native Antigen Company Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. The Native Antigen Company Virus-like Particle Product Offerings

Table 61. The Native Antigen Company Recent Development

Table 62. Creative BioStructure Company Information

Table 63. Creative BioStructure Introduction and Business Overview

Table 64. Creative BioStructure Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Creative BioStructure Virus-like Particle Product Offerings

Table 66. Creative BioStructure Recent Development

Table 67. Creative Biolabs Company Information

Table 68. Creative Biolabs Introduction and Business Overview

Table 69. Creative Biolabs Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Creative Biolabs Virus-like Particle Product Offerings

Table 71. Creative Biolabs Recent Development

Table 72. Leadgene Biomedical Company Information

Table 73. Leadgene Biomedical Introduction and Business Overview

Table 74. Leadgene Biomedical Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Leadgene Biomedical Virus-like Particle Product Offerings

Table 76. Leadgene Biomedical Recent Development

Table 77. Abcam Company Information

Table 78. Abcam Introduction and Business Overview

Table 79. Abcam Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Abcam Virus-like Particle Product Offerings

Table 81. Abcam Recent Development

Table 82. ACROBiosystems Company Information

Table 83. ACROBiosystems Introduction and Business Overview

Table 84. ACROBiosystems Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. ACROBiosystems Virus-like Particle Product Offerings

Table 86. ACROBiosystems Recent Development

Table 87. Gentarget Company Information

Table 88. Gentarget Introduction and Business Overview

Table 89. Gentarget Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Gentarget Virus-like Particle Product Offerings

Table 91. Gentarget Recent Development

Table 92. VectorBuilder Company Information

Table 93. VectorBuilder Introduction and Business Overview

Table 94. VectorBuilder Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. VectorBuilder Virus-like Particle Product Offerings

Table 96. VectorBuilder Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Virus-like Particle Downstream Customers

Table 100. Virus-like Particle Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Virus-like Particle Product Picture

Figure 2. Global Virus-like Particle Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Virus-like Particle Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Virus-like Particle Sales Volume (2019-2030) & (K Units)

Figure 5. Global Virus-like Particle Sales Price (2019-2030) & (US$/Unit)

Figure 6. Virus-like Particle Report Years Considered

Figure 7. Global Virus-like Particle Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Virus-like Particle Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Virus-like Particle Revenue in 2023

Figure 10. Virus-like Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. E. coli Picture

Figure 12. Yeast Picture

Figure 13. Insect Cells Picture

Figure 14. Others Picture

Figure 15. Global Virus-like Particle Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Virus-like Particle Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Virus-like Particle Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Virus-like Particle Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Virus-like Particle Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Vaccine

Figure 21. Product Picture of Therapeutics

Figure 22. Product Picture of Bioimaging

Figure 23. Product Picture of Others

Figure 24. Global Virus-like Particle Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Virus-like Particle Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Virus-like Particle Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Virus-like Particle Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Virus-like Particle Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America Virus-like Particle Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Virus-like Particle Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Virus-like Particle Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Virus-like Particle Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Virus-like Particle Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Virus-like Particle Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Virus-like Particle Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Virus-like Particle Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Virus-like Particle Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Virus-like Particle Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Virus-like Particle Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Virus-like Particle Sales Volume (%), (2019-2030)

Figure 41. United States Virus-like Particle Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Virus-like Particle Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Virus-like Particle Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Virus-like Particle Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Virus-like Particle Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Virus-like Particle Sales Value by Application (%), 2023 VS 2030

Figure 47. China Virus-like Particle Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Virus-like Particle Sales Value by Type (%), 2023 VS 2030

Figure 49. China Virus-like Particle Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Virus-like Particle Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Virus-like Particle Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Virus-like Particle Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Virus-like Particle Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Virus-like Particle Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Virus-like Particle Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Virus-like Particle Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Virus-like Particle Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Virus-like Particle Sales Value by Application (%), 2023 VS 2030

Figure 59. India Virus-like Particle Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Virus-like Particle Sales Value by Type (%), 2023 VS 2030

Figure 61. India Virus-like Particle Sales Value by Application (%), 2023 VS 2030

Figure 62. Virus-like Particle Industrial Chain

Figure 63. Virus-like Particle Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36F7950

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Global Quantum Biology Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39P14040

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global Sulfide Solid Electrolyte Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35C14123

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

High Performance Liquid Chromatography (HPLC) Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28K13255

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Virus-like Particle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-18N12945

Virus-like Particle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Virus-like Particle - Market Size

Virus-like Particle - Market

Report Scope

Scope of Virus-like Particle - Market Report

Chapter Outline

FAQ for this report

What is the Virus-like Particle - Market size in 2030?

Who are the main players in the Virus-like Particle - Market report?

What are the Application segmentation covered in the Virus-like Particle - Market report?

What are the Type segmentation covered in the Virus-like Particle - Market report?

FEATURED COMPANIES

RELATED REPORTS